These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32220123)

  • 1. A case of pediatric acrodermatitis continua of Hallopeau successfully treated with adalimumab biosimilar.
    Megna M; Fabbrocini G; Costa C; Ferrillo M
    Dermatol Ther; 2020 May; 33(3):e13327. PubMed ID: 32220123
    [No Abstract]   [Full Text] [Related]  

  • 2. Adalimumab treatment for acrodermatitis continua of Hallopeau: three cases refractory to IL-17 inhibition.
    Zhang Z; Wu X; Han C; Chen M; Liu Y
    J Dtsch Dermatol Ges; 2023 Jul; 21(7):785-787. PubMed ID: 37186059
    [No Abstract]   [Full Text] [Related]  

  • 3. Acrodermatitis continua of Hallopeau (ACH): two cases successfully treated with adalimumab.
    Di Costanzo L; Napolitano M; Patruno C; Cantelli M; Balato N
    J Dermatolog Treat; 2014 Dec; 25(6):489-94. PubMed ID: 24215490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of acrodermatitis continua of Hallopeau successfully treated with guselkumab.
    Buononato D; Licata G; Gambardella A; De Rosa A; Calabrese G; Argenziano G
    Dermatol Ther; 2022 Jul; 35(7):e15514. PubMed ID: 35420733
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of adalimumab for the treatment of refractory paediatric acrodermatitis continua of hallopeau.
    Dini V; Barbanera S; Romanelli M
    Acta Derm Venereol; 2013 Sep; 93(5):588-9. PubMed ID: 23407925
    [No Abstract]   [Full Text] [Related]  

  • 6. A case of acrodermatitis continua of Hallopeau evolving into generalized pustular psoriasis successfully treated with guselkumab.
    Yamamoto H; Kamiya K; Okada H; Maekawa T; Komine M; Ohtsuki M
    Int J Dermatol; 2023 Feb; 62(2):269-270. PubMed ID: 35187654
    [No Abstract]   [Full Text] [Related]  

  • 7. Acrodermatitis continua of Hallopeau successfully treated with ixekizumab: A case report.
    Battista T; Guerrasio G; De Fata Salvatores G; Peduto T; Fabbrocini G; Di Guida A
    Dermatol Ther; 2022 May; 35(5):e15383. PubMed ID: 35174591
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of acrodermatitis continua of hallopeau with ixekizumab.
    Miller AC; Holland TE; Cohen DJ
    J Dermatolog Treat; 2021 Feb; 32(1):117-119. PubMed ID: 31184530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of acrodermatitis continua of Hallopeau with adalimumab.
    Ryan C; Collins P; Kirby B; Rogers S
    Br J Dermatol; 2009 Jan; 160(1):203-5. PubMed ID: 18945314
    [No Abstract]   [Full Text] [Related]  

  • 10. Acrodermatitis continua of Hallopeau successfully treated with adalimumab: A case report.
    Crowley EL; Maliyar K; Rodriguez-Bolanos F; O'Toole A; Gooderham MJ
    SAGE Open Med Case Rep; 2019; 7():2050313X19829620. PubMed ID: 30800311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acrodermatitis continua of hallopeau successfully treated with adalimumab.
    Sopkovich JA; Anetakis Poulos G; Wong HK
    J Clin Aesthet Dermatol; 2012 Feb; 5(2):60-2. PubMed ID: 22468174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brodalumab in the treatment of recalcitrant acrodermatitis continua of Hallopeau.
    Bardazzi F; Di Altobrando A; Lacava R
    Dermatol Ther; 2020 Nov; 33(6):e14301. PubMed ID: 32920959
    [No Abstract]   [Full Text] [Related]  

  • 13. The Use of Biologic Therapy in the Treatment of Acrodermatitis Continua of Hallopeau: A Review.
    Maliyar K; Crowley EL; Rodriguez-Bolanos F; O'Toole A; Gooderham MJ
    J Cutan Med Surg; 2019; 23(4):428-435. PubMed ID: 30938189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acrodermatitis continua of Hallopeau successfully treated with secukinumab.
    Balestri R; Rech G; Tasin L; Rizzoli L; Girardelli CR
    J Dermatolog Treat; 2018; 29(sup1):3-5. PubMed ID: 30246571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adalimumab for a co-existing clinical condition of Crohn's disease and acrodermatitis continua of Hallopeau.
    Caputo F; Parro S; Zoli G
    J Crohns Colitis; 2011 Dec; 5(6):649. PubMed ID: 22115391
    [No Abstract]   [Full Text] [Related]  

  • 16. Treating paediatric acrodermatitis continua of Hallopeau with adalimumab: a case series.
    Wang Z; Xiang X; Chen Y; Zhao X; Liu Y; Xu Z; Ma L
    Clin Exp Dermatol; 2022 Jan; 47(1):195-196. PubMed ID: 34559906
    [No Abstract]   [Full Text] [Related]  

  • 17. Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literature.
    Galluzzo M; D'Adamio S; Teoli M; Bianchi L; Talamonti M
    Dermatol Ther; 2019 May; 32(3):e12899. PubMed ID: 30969010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acrodermatitis continua of Hallopeau: treatment with etretinate and review of relapsing pustular eruptions of the hands and feet.
    Pearson LH; Allen BS; Smith JG
    J Am Acad Dermatol; 1984 Oct; 11(4 Pt 2):755-62. PubMed ID: 6491002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of acrodermatitis continua of Hallopeau with TNF-blocking agents: case report and review.
    Puig L; Barco D; Vilarrasa E; Alomar A
    Dermatology; 2010; 220(2):154-8. PubMed ID: 20110631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of recalcitrant acrodermatitis continua of Hallopeau with adalimumab and acitretin.
    Tobin AM; Kirby B
    Br J Dermatol; 2005 Aug; 153(2):445-6. PubMed ID: 16086767
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.